In an unusual move, the drugmaker Regeneron is making the treatment available for free to patients in the United States.
A new international study co-led by investigators from Mass General Brigham and the Eye & ENT Hospital of Fudan University shows that a gene therapy for a rare form of genetic deafness successfully ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results